Dichloroacetic Acid (DCA) Synergizes With the SIRT2 Inhibitor Sirtinol and AGK2 to Enhance Anti-Tumor Efficacy in Non-Small Cell Lung Cancer

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2018.1480281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Oxymatrine and Cisplatin Synergistically Enhance Anti-Tumor Immunity of CD8+ T Cells in Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Constitutive Androstane Receptor Ligands Modulate the Anti-Tumor Efficacy of Paclitaxel in Non-Small Cell Lung Cancer Cells

PLoS ONE
Multidisciplinary
2014English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Epigenetic Modulation With HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells

PLoS ONE
Multidisciplinary
2015English

Profiling Non-Small Cell Lung Cancer: From Tumor to Blood

Clinical Cancer Research
Cancer ResearchOncology
2015English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2017English

Interference With Netrin-1 and Tumor Cell Death in Non–Small Cell Lung Cancer

Journal of the National Cancer Institute
Cancer ResearchOncology
2009English

Circulating Tumor Microemboli Diagnostics for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy